I
IN8BIO, Inc.
NASDAQ:INAB
IN8BIO, Inc.
NASDAQ:INAB
Price:
1.41
USD
-2.08%
Market Closed
Market Cap:
$13.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
IN8BIO, Inc.
NASDAQ:INAB
|
US |
Balance Sheet
Balance Sheet Decomposition
IN8BIO, Inc.
IN8BIO, Inc.
Balance Sheet Decomposition is not available for
IN8BIO, Inc.
IN8BIO, Inc.
Balance Sheet
IN8BIO, Inc.
IN8BIO, Inc.
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
5
|
1
|
18
|
37
|
18
|
21
|
11
|
27
|
|
| Cash |
5
|
1
|
18
|
37
|
18
|
21
|
11
|
27
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
2
|
4
|
3
|
1
|
1
|
|
| Total Current Assets |
5
|
1
|
18
|
39
|
22
|
25
|
13
|
28
|
|
| PP&E Net |
1
|
0
|
0
|
3
|
10
|
9
|
8
|
4
|
|
| PP&E Gross |
1
|
0
|
0
|
3
|
10
|
9
|
8
|
4
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
|
| Other Long-Term Assets |
0
|
0
|
3
|
0
|
1
|
1
|
1
|
0
|
|
| Total Assets |
6
N/A
|
1
-81%
|
21
+1 750%
|
42
+102%
|
33
-22%
|
34
+2%
|
21
-38%
|
32
+54%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
1
|
1
|
0
|
2
|
1
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
2
|
1
|
3
|
4
|
2
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Total Current Liabilities |
0
|
1
|
3
|
2
|
6
|
5
|
3
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
0
|
2
|
4
|
3
|
3
|
2
|
|
| Total Liabilities |
1
N/A
|
1
+18%
|
3
+75%
|
4
+56%
|
10
+155%
|
9
-15%
|
6
-26%
|
5
-27%
|
|
| Equity | |||||||||
| Common Stock |
9
|
9
|
35
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
4
|
9
|
18
|
33
|
61
|
91
|
122
|
141
|
|
| Additional Paid In Capital |
0
|
0
|
1
|
71
|
84
|
116
|
136
|
169
|
|
| Total Equity |
5
N/A
|
0
N/A
|
18
N/A
|
38
+108%
|
23
-40%
|
25
+10%
|
14
-42%
|
28
+90%
|
|
| Total Liabilities & Equity |
6
N/A
|
1
-81%
|
21
+1 750%
|
42
+102%
|
33
-22%
|
34
+2%
|
21
-38%
|
32
+54%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
10
|
|
Switch to:
Switch to:
See Also
Discover More
